Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease

• Published in: Nucleic acids research Vol. 35; no. 22; pp. 7497 - 7504
• Main Authors: Lovell, Mark A., Markesbery, William R.
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01.12.2007; Oxford Publishing Limited (England)
• Subjects: acrolein; Aged; Aged, 80 and over; Aldehydes; Alzheimer disease; Alzheimer Disease - diagnosis; Alzheimer Disease - genetics; Alzheimer Disease - pathology; Alzheimer's disease; byproducts; Chemical degradation; Cognition Disorders - diagnosis; Cognition Disorders - genetics; Cognitive ability; crosslinking; cytosine; DNA - chemistry; DNA - metabolism; DNA Damage; DNA Repair; guanine; hippocampus; Humans; Hydroxyl radicals; lipid peroxidation; Mitochondrial DNA; mutation; neurodegenerative diseases; nuclear genome; Oxidation-Reduction; Oxidative Stress; Peroxidation; Protein synthesis; Survey and Summary
• ISSN: 0305-1048; 1362-4962; 1362-4962
• DOI: 10.1093/nar/gkm821

Increasing evidence supports a role for oxidative DNA damage in aging and several neurodegenerative diseases including Alzheimer's disease (AD). Attack of DNA by reactive oxygen species (ROS), particularly hydroxyl radicals, can lead to strand breaks, DNA–DNA and DNA–protein cross-linking, and formation of at least 20 modified bases adducts. In addition, α,β-unsaturated aldehydic by-products of lipid peroxidation including 4-hydroxynonenal and acrolein can interact with DNA bases leading to the formation of bulky exocyclic adducts. Modification of DNA bases by direct interaction with ROS or aldehydes can lead to mutations and altered protein synthesis. Several studies of DNA base adducts in late-stage AD (LAD) brain show elevations of 8-hydroxyguanine (8-OHG), 8-hydroxyadenine (8-OHA), 5-hydroxycytosine (5-OHC), and 5-hydroxyuracil, a chemical degradation product of cytosine, in both nuclear and mitochondrial DNA (mtDNA) isolated from vulnerable regions of LAD brain compared to age-matched normal control subjects. Previous studies also show elevations of acrolein/guanine adducts in the hippocampus of LAD subjects compared to age-matched controls. In addition, studies of base excision repair show a decline in repair of 8-OHG in vulnerable regions of LAD brain. Our recent studies show elevated 8-OHG, 8-OHA, and 5,6-diamino-5-formamidopyrimidine in both nuclear and mtDNA isolated from vulnerable brain regions in amnestic mild cognitive impairment, the earliest clinical manifestation of AD, suggesting that oxidative DNA damage is an early event in AD and is not merely a secondary phenomenon.